Mitra Nadim United States

Dr. Nadim is a Professor of Clinical Medicine and Director of Critical Care Nephrology at Keck Hospital of USC. She is nationally and internationally known nephrologist with expertise in the area of acute kidney injury in critically ill patients in the ICU, especially those with end-stage liver disease Over the past several years, she has co-organized several international consensus meetings that have resulted in significant contribution to the field of acute kidney injury, hepatology and liver transplantation. These include Consensus meeting on 1) Hepatorenal Syndrome, which became one of the most significant contributions to the field of liver transplantation as it re-defined HRS-AKI / AKI in patients with liver disease, 2) guidelines for simultaneous liver-kidney transplantation 3) International multidisciplinary consensus meeting on the Management of Critically Ill Patients with Cirrhosis awaiting Liver Transplantation, which has become a basis for management of this patient population, 4) Acute kidney injury in patients with Cardiac and Vascular Surgery and 5) AKI in patients with COVID-19. She is the author of more than 100 articles, reviews and book chapters.

19th September 2026 Saturday

Time	Session

07:30 08:15	Meet the Expert 1 How do I Manage Patients with Acute Liver Failure Chieh-Hsin Huang Moderator How do I Manage Patients with Acute Liver Failure Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure Room 1
08:30 10:15	Plenary 1: Organ Dysfunction in the Critically Ill Patient: Emerging Concepts Chih-Wei Yang Moderator Opening Remarks Ravindra Mehta Speaker Opening Remarks Ji-Tseng Fang Speaker Organ Crosstalk in AKI Kent Doi Speaker Organ crosstalk in AKITargeted Polymyxin B Hemadsorption in Sepsis: Lessons from Japanese Experience and Patient Selection Kidney-Ventilator Interactions and Kidney Protective Ventilation /Lung and Kidney Crosstalk Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Latrogenic Failure Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure Special Lecture: 50 years of CRRT: A Journey Through Innovation Claudio Ronco Speaker Hemoadsorption in the ICUSpecial lecture: 50 years of CRRT: a journey through innovationRole of Renal Functional Reserve on AKI risk and RecoveryHow do I use Hemadsorption in My PracticeManaging the Heart Failure Patient With Worsening Renal Function (WRF) Q & A Room 1
14:00 15:30	Workshop 1 - Session B Managing Patients With Combined Kidney and Liver Failure Managing Patients With Combined Kidney and Liver Failure Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure Ju-Yeh Yang Moderator Room 2